Eric Karas

Corporate Officer/Principal bei ARS PHARMACEUTICALS, INC.

Vermögen: - $ am 31.05.2024

52 Jahre

Health Technology

Consumer Services

Aktive Positionen von Eric Karas

Unternehmen	Position	Beginn	Ende
ARS PHARMACEUTICALS, INC.	Corporate Officer/Principal	08.11.2022	-
ARS Subsidiary, Inc. ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA.	Corporate Officer/Principal	01.04.2022	-

Unternehmen	Position	Beginn	Ende
EMERGENT BIOSOLUTIONS INC.	Corporate Officer/Principal	01.10.2018	01.03.2022

Eli Broad College of Business	Masters Business Admin
Rutgers State University of New Jersey	Undergraduate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	3
Masters Business Admin	1
Undergraduate Degree	1

Sektoral

Health Technology	4
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
ARS PHARMACEUTICALS, INC.	Health Technology
EMERGENT BIOSOLUTIONS INC.	Health Technology

Private Unternehmen	1
ARS Subsidiary, Inc. ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA.	Health Technology